What is the equity of KoBioLabs this year?
KoBioLabs has equity of 44.95 B KRW this year.
KoBioLabs Equity 2024
KoBioLabs Equity
44.95 B KRW
Ticker
348150.KQ
ISIN
KR7348150004
In 2024, KoBioLabs's equity was 44.95 B KRW, a -41.87% increase from the 77.32 B KRW equity in the previous year.
KoBioLabs Aktienanalyse
What does KoBioLabs do?
KoBioLabs ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing KoBioLabs's Equity
KoBioLabs's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding KoBioLabs's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating KoBioLabs's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
KoBioLabs's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in KoBioLabs’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about KoBioLabs stock
What was the equity of KoBioLabs compared to the previous year?
The equity of KoBioLabs has increased/decreased by -41.87% decreased compared to the previous year.
What impact does a high equity have on investors of KoBioLabs?
A high equity is advantageous for investors of KoBioLabs as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of KoBioLabs?
A low equity can be a risk for investors of KoBioLabs, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of KoBioLabs affect the company?
An increase in equity of KoBioLabs can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of KoBioLabs affect the company?
A reduction in equity of KoBioLabs can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of KoBioLabs?
Some factors that can affect the equity of KoBioLabs include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of KoBioLabs so important for investors?
The equity of KoBioLabs is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can KoBioLabs take to change the equity?
To change equity, KoBioLabs can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does KoBioLabs pay?
Over the past 12 months, KoBioLabs paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, KoBioLabs is expected to pay a dividend of 0 KRW.
What is the dividend yield of KoBioLabs?
The current dividend yield of KoBioLabs is .
When does KoBioLabs pay dividends?
KoBioLabs pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of KoBioLabs?
KoBioLabs paid dividends every year for the past 0 years.
What is the dividend of KoBioLabs?
For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.
In which sector is KoBioLabs located?
KoBioLabs is assigned to the 'Health' sector.
Wann musste ich die Aktien von KoBioLabs kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of KoBioLabs from 11/29/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 11/29/2024.
When did KoBioLabs pay the last dividend?
The last dividend was paid out on 11/29/2024.
What was the dividend of KoBioLabs in the year 2023?
In the year 2023, KoBioLabs distributed 0 KRW as dividends.
In which currency does KoBioLabs pay out the dividend?
The dividends of KoBioLabs are distributed in KRW.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von KoBioLabs
Our stock analysis for KoBioLabs Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of KoBioLabs Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.